Author

Tim Crook

Institution: Bupa Cromwell Hospital

Observed institution: Bupa Cromwell Hospital

ORCID: 0009-0009-7232-3507

Observed ORCID: 0009-0009-7232-3507

OpenAlex ID: A5136832852

Integrated tumor-informed and tumor-agnostic ctDNA molecular residual disease (MRD) assessment with imaging in early breast cancer.

2026 · Tim Crook, Ashok K. Vaid, et al. · Journal of Clinical Oncology · 1

Triple-Negative Transformation in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: Tissue Versus Liquid Biopsy in Two Cases

2026 · Shahla Abu Naib, Paul Ellis, et al. · JCO Precision Oncology

Metastatic Hormone Receptor+ Breast Cancer at ASCO 2026: Endocrine Resistance, Precision Monitoring, and Emerging Sequencing Strategies

2026 · Francois-Clement Bidard, Nicholas Turner, et al. · Oncology The American Medical Journal

Beyond ESR1 : Multi-pathway genomic drivers of endocrine resistance in HR⁺/HER2⁻ breast cancer.

2026 · Humaid Obaid Al-Shamsi, Massimo Cristofanilli, et al. · Journal of Clinical Oncology

Comprehensive molecular analysis of synchronous liver metastases identifies independent drivers of metastasis and endocrine resistance in hormone receptor–positive breast cancer

2026 · Shahla Abu Naib, Eisa Velicaria, et al. · Medical Reports

Attention-Enhanced U-Net Segmentation for Reliable Detection of Circulating Tumor-Associated Cells

2026 · Darshana Patil, Massimo Cristofanilli, et al. · Research Square

Works count: 6

Citation count: 1

H-index: 1

I10-index: